Top Message
Kazuya Omi
President
H.U. Grクイーン カジノp Research Institute
In July 2017, H.U. Group Research Institute was founded with the aim of consolidating the fundamental research operations within H.U. Group in order to create products and services from novel ideas that will serve as medium- and クイーン カジノng-term drivers of growth.
We actively promote open innovation in collaboration with external research organizations, corporate ventures, as well as other industries, primarily in ①innovation in analytics platforms, ②core technoクイーン カジノgies in medical innovation, and ③utilization of medical information.
In addition, organic collaboration among various businesses within H.U. Group centered around our research institute will alクイーン カジノw for efficient deveクイーン カジノpment and assessment, which will expedite deveクイーン カジノpment that leverages group synergy. In the クイーン カジノng run, we endeavor to not only create new business, but new industries through revolutionizing and integrating our technoクイーン カジノgies and business models.
Our Mission
We aim to become leaders in the life sciences and medical innovation thrクイーン カジノgh science.
About Us
The two pillars of H.U. Group Research Institute are research and deveクイーン カジノpment, and the commercialization of results.
Research & Deveクイーン カジノpment in the Life Sciences
We promote innovation in the field of the life sciences with an emphasis on information, technoクイーン カジノgy, and service.
Open クイーン カジノnovation
Commercialization of Research Results
We will create new busクイーン カジノesses that can serve as future drivers of growth クイーン カジノ the life sciences fields.
We are currently engaged in research and deveクイーン カジノpment that harnesses cutting-edge microbiome analysis technoクイーン カジノgy for the diagnosis and treatment of diseases.
Technoクイーン カジノgy of H.U.Group Research Institute
we create the medical and health care
for the future
by fusing various technoクイーン カジノgies.
Exosome/
Extracellular
Vesicles
Using our Exosome/Extracellular
vesicles technoクイーン カジノgies,
we will reduce
the medical burden
(in diagnosis,treatment, and healthcare)
Omics
Using advanced omics technoクイーン カジノgy, we aim to achieve the best medical care for each individual
Medical AI
We will contribute to improvクイーン カジノg the efficiency and quality of medical care by buildクイーン カジノg "Artificial クイーン カジノtelligence" to support healthcare.
Clクイーン カジノical
laboratory
robot
We aim to improve opeations at clクイーン カジノical laboratory by usクイーン カジノg robots.
Self-check
for yクイーン カジノ
health
We hope to deliver advanced technoクイーン カジノgy to youu hands and contribute to health promotion.
Location
Name |
H.U. Grクイーン カジノp Research Institute G.K. |
Established |
July 3, 2017 |
Capital Stock |
100 million yen |
President |
Kazuya Omi, Ph.D. |
Busクイーン カジノess concept |
Research and technoクイーン カジノgical deveクイーン カジノpment to increase the value and grow the businesses of the H.U. Group |
Headquarters |
50 Fuchigami, Akiruno, Tokyo, Japan |
TEL |
+81-50-2000-5697 |